News Updates from the healthcare landscape and the impact of Algocyte. OIA 21/02/2026 OIA 21/02/2026 Algocyte Expands International Research Deployment across North America & the Middle East Read More OIA 31/01/2026 OIA 31/01/2026 Algocyte Welcomes Dr Pradip Banerjee as New Board Director Read More OIA 01/12/2025 OIA 01/12/2025 'Hospital of the Future' at New Scientist Live 2025 with Algocyte Voted Festival’s Most Popular Feature Read More OIA 04/11/2025 OIA 04/11/2025 Oxford Immune Algorithmics® reveals the Future of Blood Testing with Algocyte® at London’s New Scientist Live Festival Read More OIA 03/10/2025 OIA 03/10/2025 Avatrial and OIA Announce Partnership: Building Together the Future of Immune Health and Precision Oncology for Drug Discovery Read More OIA 02/06/2025 OIA 02/06/2025 Oxford Immune Algorithmics Gains Access to 60 million Anonymised Medical records and Deploys Algocyte® Devices for Testing and Validation with Leading NHS Hospitals in England Read More OIA 26/01/2025 OIA 26/01/2025 Lord Darzi Team Visit OIA to Discuss the Potential of Algocyte to Solve a Human Health Challenge Read More OIA 17/12/2024 OIA 17/12/2024 University of Harvard group and Dr. Eric Topol's interpretation of new Nature paper validates Algocyte's and OIA's main value proposition Read More OIA 13/09/2024 OIA 13/09/2024 OIA Founder Dr. Hector Zenil at prestigious industry panel of life science leaders on the future of ageing Read More OIA 05/07/2024 OIA 05/07/2024 AI Dialogue with History: How the Past Will Forge Our Future to Transform Healthcare Read More OIA 31/03/2024 OIA 31/03/2024 Oxford Immune Algorithmics (OIA) Successfully Completes ISO 27001 Read More OIA 29/01/2024 OIA 29/01/2024 Oxford Immune Algorithmics Signs Agreement with the Alan Turing Institute Read More OIA 29/11/2023 OIA 29/11/2023 A(G)I Definition, Safety, Regulation White Paper Read More OIA 08/11/2023 OIA 08/11/2023 OIA Featured on the NHS 75th Anniversary Book, IFA, CogX and Bloomberg TV Read More OIA 15/05/2023 OIA 15/05/2023 OIA Maintains ISO 13485 (QMS Medical Devices) Certification with Zero Non-Conformities Read More OIA 15/05/2023 OIA 15/05/2023 OIA Welcomes New Strategic Investor Mark Stevenson & New Board Advisor Abel Archundia to Drive Growth & Innovation in AI-Powered Precision Medicine Read More OIA 04/03/2023 OIA 04/03/2023 Oxford Immune Algorithmics’ CEO participates at the Ferguson Summit with fellow founders and investors in Florida Read More Hector Zenil 04/03/2023 Hector Zenil 04/03/2023 OIA and Algocyte to be Featured on Ted Danson’s Advancements TV show on Bloomberg TV and Amazon Prime Video Read More OIA 04/02/2023 OIA 04/02/2023 Presenting Algocyte in the Metaverse at Arab Health 2024 — Second consecutive year at the global healthcare medical expo, Dubai Read More OIA 11/12/2022 OIA 11/12/2022 Q&A with OIA’s Founder: Complexity Frontiers Read More Older Posts
OIA 21/02/2026 OIA 21/02/2026 Algocyte Expands International Research Deployment across North America & the Middle East Read More
OIA 01/12/2025 OIA 01/12/2025 'Hospital of the Future' at New Scientist Live 2025 with Algocyte Voted Festival’s Most Popular Feature Read More
OIA 04/11/2025 OIA 04/11/2025 Oxford Immune Algorithmics® reveals the Future of Blood Testing with Algocyte® at London’s New Scientist Live Festival Read More
OIA 03/10/2025 OIA 03/10/2025 Avatrial and OIA Announce Partnership: Building Together the Future of Immune Health and Precision Oncology for Drug Discovery Read More
OIA 02/06/2025 OIA 02/06/2025 Oxford Immune Algorithmics Gains Access to 60 million Anonymised Medical records and Deploys Algocyte® Devices for Testing and Validation with Leading NHS Hospitals in England Read More
OIA 26/01/2025 OIA 26/01/2025 Lord Darzi Team Visit OIA to Discuss the Potential of Algocyte to Solve a Human Health Challenge Read More
OIA 17/12/2024 OIA 17/12/2024 University of Harvard group and Dr. Eric Topol's interpretation of new Nature paper validates Algocyte's and OIA's main value proposition Read More
OIA 13/09/2024 OIA 13/09/2024 OIA Founder Dr. Hector Zenil at prestigious industry panel of life science leaders on the future of ageing Read More
OIA 05/07/2024 OIA 05/07/2024 AI Dialogue with History: How the Past Will Forge Our Future to Transform Healthcare Read More
OIA 31/03/2024 OIA 31/03/2024 Oxford Immune Algorithmics (OIA) Successfully Completes ISO 27001 Read More
OIA 29/01/2024 OIA 29/01/2024 Oxford Immune Algorithmics Signs Agreement with the Alan Turing Institute Read More
OIA 08/11/2023 OIA 08/11/2023 OIA Featured on the NHS 75th Anniversary Book, IFA, CogX and Bloomberg TV Read More
OIA 15/05/2023 OIA 15/05/2023 OIA Maintains ISO 13485 (QMS Medical Devices) Certification with Zero Non-Conformities Read More
OIA 15/05/2023 OIA 15/05/2023 OIA Welcomes New Strategic Investor Mark Stevenson & New Board Advisor Abel Archundia to Drive Growth & Innovation in AI-Powered Precision Medicine Read More
OIA 04/03/2023 OIA 04/03/2023 Oxford Immune Algorithmics’ CEO participates at the Ferguson Summit with fellow founders and investors in Florida Read More
Hector Zenil 04/03/2023 Hector Zenil 04/03/2023 OIA and Algocyte to be Featured on Ted Danson’s Advancements TV show on Bloomberg TV and Amazon Prime Video Read More
OIA 04/02/2023 OIA 04/02/2023 Presenting Algocyte in the Metaverse at Arab Health 2024 — Second consecutive year at the global healthcare medical expo, Dubai Read More
